Biotech

MassBio Recognizes Three Biotech and Pharma Companies with Awards at Annual State of Possible Conference

April 25, 2024

Morphoceuticals Names Jim Jenson, PhD as CEO to Advance AI-Guided Regenerative Medicine Technology

April 18, 2024

PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions

April 9, 2024

New England Biolabs Leases 28,000 SF

December 7, 2020

Walgreens Boots Alliance Appoints Bryan C. Hanson to Board of Directors

October 28, 2022

Immunology biotech firm to relocate from Cambridge to Woburn

November 18, 2021

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

U.S. FDA Approves Pfizer’s BEQVEZ™, a One-Time Gene Therapy for Adults with Hemophilia B

Invensify Introduces the Industry’s Most Energy Efficient Cold Chain Shipping Transporter

MassBio Recognizes Three Biotech and Pharma Companies with Awards at Annual State of Possible Conference

Hera Biotech Announces Positive Interim Results From Endometriosis Diagnostic Study

Thermedical Successfully Completes Feasibility Study for Treating Cardiac Arrhythmias Using Pulsed Field Ablation in Combination with SERF Ablation

Most Read

Manulife Investment Management Announces Forest Climate Fund’s Second Close Bringing Total Commitments Up to $334.5 Million

U.S. FDA Approves Pfizer’s BEQVEZ™, a One-Time Gene Therapy for Adults with Hemophilia B

LumaBridge Appoints Todd Lehman as Chief Executive Officer

Invensify Introduces the Industry’s Most Energy Efficient Cold Chain Shipping Transporter

EDITOR PICKS

MassBio Recognizes Three Biotech and Pharma Companies with Awards at Annual State of Possible Conference

Morphoceuticals Names Jim Jenson, PhD as CEO to Advance AI-Guided Regenerative Medicine Technology

PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions

POPULAR POSTS

New England Biolabs Leases 28,000 SF

Walgreens Boots Alliance Appoints Bryan C. Hanson to Board of Directors

Immunology biotech firm to relocate from Cambridge to Woburn

POPULAR CATEGORY

ABOUT US

FOLLOW US